.jpg)
The Centre for Eye Research Australia (CERA) is an independent Medical Research Institute, deeply committed to conducting eye research with real-life impact and finding ways to prevent people from going blind.
As an international leader in eye research, CERA uses world-class knowledge and expertise to achieve better treatments and faster diagnosis of eye disease.
With the support of funders, philanthropic supporters, and partners – including Orthoptics Australia –, CERA can continue their world-leading research and accomplish scientific breakthroughs previously deemed unachievable.
With CERA, there's hope in sight®.
Referrals of patients to take part in CERA's clinical trials are welcome. Clinical trials help accelerate the pace of research and develop better treatments for patients with eye disease.
Healthcare practitioners can refer patients who may be suitable for different trials.
Individuals can also let CERA know if they wish to register their interest for future trials.
You can keep up to date with CERA’s current clinical trials here.
Eye-health care professionals and those interested in eye research and the latest news at CERA are welcome to subscribe to Eye-News, a free monthly email with the latest news and stories from CERA including new research, expert eye health information, upcoming events, and more.
Visionary is a free magazine published twice a year and mailed or emailed to donors and supporters of CERA. Visionary helps keep you up to date with the latest news and current research from CERA. Sign up to receive a copy or view the latest editions.
CERA also has a number of free guides, tools and resources to provide essential information about eye conditions such as age-related macular degeneration, glaucoma and healthy ageing eyes.
Donate to CERA to make a real impact on eye research and those affected by vision loss and blindness.
Supporting CERA's work helps bring hope to people affected by vision loss, now and in the future.
Follow CERA on Facebook, LinkedIn and Twitter for the latest news and opportunities.